IMMUCELL CORP /DE/ — Director's Dealing 2022

Feb 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-01-31

Reporting Person: BRIGHAM MICHAEL F (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-31	Incentive Stock Options (Right to buy)	$8.1500	A	1000.0000	Acquired	2032-01-31	Common Stock (1000.0000)	Direct

Footnotes

F1: This stock option grant is made subject to the reservation of more shares for the Company's 2017 Stock Option Plan by vote of stockholders at the 2022 Annual Meeting of the Company.